Its gene therapy candidate AT-GTX-501 has Fast Track designation for this indication. Recent clinical data suggest early signs of disease stabilization ...
https://www.google.com/url?rct=j&sa=t&url=https://seekingalpha.com/article/4417663-assessing-amicus-therapeutics-after-trial-results&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNFRE1fYS0BdGBkZljPydgC-kGljvQ
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.